EzriRx Revenue and Competitors
Estimated Revenue & Valuation
- EzriRx's estimated annual revenue is currently $4.2M per year.
- EzriRx's estimated revenue per employee is $201,000
Employee Data
- EzriRx has 21 Employees.
- EzriRx grew their employee count by 11% last year.
EzriRx's People
Name | Title | Email/Phone |
---|---|---|
1 | Ruby On Rails Developer | Reveal Email/Phone |
2 | Founder/CEO | Reveal Email/Phone |
3 | Pharmacy Success | Reveal Email/Phone |
4 | Ruby on Rails Developer | Reveal Email/Phone |
5 | Frontend Engineer | Reveal Email/Phone |
EzriRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is EzriRx?
EzriRx.com is the premier way to shop for pharmaceuticals and get the biggest bang for your buck. Instead of buying from a single source, shop from 20+ wholesalers all on one central website. It's the guaranteed way to ensure you're receiving the best prices for your Brand, Generics and OTC's. Think Amazon, but for Pharmacies. EzriRx allows you to track invoices from multiple suppliers, make payments online and receive Pedigree documents in one place with the click of a button. Sign up takes under 2 minutes and is 100% Free for pharmacies. EzriRx.com is the #1 Pharmacy Rated Marketplace! One Platform, Many Wholesalers = Amazing Deals!
keywords:N/AN/A
Total Funding
21
Number of Employees
$4.2M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.3M | 21 | 0% | N/A |
#2 | $3.5M | 22 | -4% | N/A |
#3 | $4.2M | 22 | -12% | N/A |
#4 | $4.2M | 22 | -8% | N/A |
#5 | $2.2M | 22 | 10% | N/A |